6.33

2.62% -0.17

After Hours: 6.33

Shattuck Labs Inc (STTK)

Overview News Price History Option Chain Financials Discussions Forecast

Shattuck Labs Inc stock is traded at $6.33, with a volume of 1.06M. It is down -2.62% in the last 24 hours and down -12.93% over the past month. Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

Previous Close:

$6.50

Open:

$6.39

24h Volume:

1.06M

Relative Volume:

0.80

Market Cap:

$635.30M

Revenue:

$1,000.00K

Net Income/Loss:

$-48.81M

P/E Ratio:

-8.1815

EPS:

-0.7737

Net Cash Flow:

$-39.95M

1W Performance:

-8.39%

1M Performance:

-12.93%

6M Performance:

+5.15%

1Y Performance:

+214.93%

1-Day Range:

$6.245

$6.57

1-Week Range:

$6.245

$7.045

52-Week Range:

$1.68

$8.33

Shattuck Labs Inc Stock (STTK) Company Profile

Name

Shattuck Labs Inc

Sector

Healthcare (1069)

Industry

Biotechnology (601)

Phone

512-900-4690

Address

500 W. 5TH STREET, AUSTIN

Employee

Twitter

Next Earnings Date

2026-08-13

Latest SEC Filings

STTK's Discussions on Twitter

Compare STTK vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
STTK Shattuck Labs Inc	6.33	652.36M	1,000.00K	-48.81M	-39.95M	-0.7737
VRTX Vertex Pharmaceuticals Inc	521.12	134.06B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	807.65	83.43B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,002.31	63.00B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	135.61	56.02B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	207.68	44.44B	742.00K	-1.37B	-1.07B	-7.0731

Shattuck Labs Inc Stock (STTK) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-27-26	Initiated	Cantor Fitzgerald	Overweight
Mar-06-26	Resumed	Needham	Buy
Jan-28-26	Initiated	Piper Sandler	Overweight
Dec-01-25	Upgrade	H.C. Wainwright	Neutral → Buy
Sep-08-25	Initiated	Wedbush	Outperform
Mar-17-25	Initiated	Leerink Partners	Outperform
Oct-02-24	Downgrade	Citigroup	Buy → Neutral
Oct-02-24	Downgrade	Needham	Buy → Hold
Oct-01-24	Downgrade	H.C. Wainwright	Buy → Neutral
Jun-17-24	Downgrade	BTIG Research	Buy → Neutral
Aug-31-22	Initiated	BTIG Research	Buy
Jun-01-22	Initiated	Citigroup	Buy
May-02-22	Initiated	H.C. Wainwright	Buy
Apr-14-21	Initiated	Berenberg	Buy
Jan-11-21	Initiated	Evercore ISI	Outperform
Nov-03-20	Initiated	Citigroup	Buy
Nov-03-20	Initiated	Cowen	Outperform
Nov-03-20	Initiated	Needham	Buy

View All

Shattuck Labs Inc Stock (STTK) Latest News

Sep 08, 2026

Shattuck Labs at Wells Fargo conference: DR3 bet takes center stage - Investing.com Canada

Sep 08, 2026

Sep 04, 2026

SHATTUCK LABS STOCK : BIG PRICE RECOVERY | STTK STOCK Darpa Autonomous Drone Swarms (RwCs7APen5) - mshale.com

Sep 04, 2026

Sep 02, 2026

Shattuck Labs Announces Participation in Upcoming September Investor Conferences - Investing News Network

Sep 02, 2026

Sep 01, 2026

Shattuck Labs: A Receptor-Side Bet On The TL1A Boom - Seeking Alpha

Sep 01, 2026

Aug 28, 2026

STTK Q2 2026 Earnings: Fractional EPS Miss Triggers 6.67% Selloff in Clinical-Stage BiotechUpward Estimate Revision - vinanet.vn

Aug 28, 2026

Aug 24, 2026

Raymond James Initiates Coverage on Shattuck Labs With Strong Buy Rating, $18 Price Target - marketscreener.com

Aug 24, 2026

Raymond James initiates Shattuck Labs stock with strong buy rating - Investing.com

Aug 24, 2026

Raymond James initiates Shattuck Labs stock with strong buy rating By Investing.com - Investing.com UK

Aug 24, 2026

What Shattuck Labs Stock Topped the Market on Monday - Yahoo Finance

Aug 24, 2026

Aug 23, 2026

Shattuck (STTK) EPS and Revenue: The EPS Result Is Above Expectation at the Close; Share Response: Shares Move 3.86% Up for the Current SessionEarnings Expansion Phase - vinanet.vn

Aug 23, 2026

Aug 22, 2026

Shattuck (STTK) Momentum: Records a 3.86% Increase to $7.53 in the Latest Reading; Level Watch: the $7.15 to $7.91 Range Remains in Focus in the Latest SessionSweep Order Flow - vinanet.vn

Aug 22, 2026

Aug 21, 2026

Shattuck Labs expects ~$59.4M proceeds from exercised warrants - scanx.trade

Aug 21, 2026

Aug 20, 2026